Listed

Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Sep 28, 2019

Filed with the SEC on Nov 1, 2019 and accepted by EDGAR at Nov 1, 2019, 10:56 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-28. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-06-30 to 2019-09-28$6.27bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2019-01-01 to 2019-09-28$18.71bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2019-06-30 to 2019-09-28$247.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2019-01-01 to 2019-09-28$741.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-06-30 to 2019-09-28$1.54bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2019-01-01 to 2019-09-28$4.63bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-06-30 to 2019-09-28$946.0mus-gaap:OperatingIncomeLoss
Operating income9 months2019-01-01 to 2019-09-28$3.36bnus-gaap:OperatingIncomeLoss
Interest expense3 months2019-06-30 to 2019-09-28$164.0mus-gaap:InterestExpense
Interest expense9 months2019-01-01 to 2019-09-28$534.0mus-gaap:InterestExpense
Income tax3 months2019-06-30 to 2019-09-28$62.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-01-01 to 2019-09-28$338.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-06-30 to 2019-09-28$760.0mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2019-01-01 to 2019-09-28$2.69bnus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2019-06-30 to 2019-09-28$1.88us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-01-01 to 2019-09-28$6.68us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-06-30 to 2019-09-28$1.89us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-01-01 to 2019-09-28$6.73us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-06-30 to 2019-09-28404,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-01-01 to 2019-09-28403,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-01-01 to 2019-09-28$3.06bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-01-01 to 2019-09-28$637.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2019-01-01 to 2019-09-28$221.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2019-01-01 to 2019-09-28$750.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-09-28$1.27bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-28$10.51bnus-gaap:AssetsCurrent
Total assetsAt period end2019-09-28$56.73bnus-gaap:Assets
Current liabilitiesAt period end2019-09-28$5.84bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2019-09-28$16.39bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-09-28$661.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2019-09-28$29.36bnus-gaap:StockholdersEquity
Shares outstandingAt period end2019-09-28400,991,227 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000097745-19-000049. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.